Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Topic: Health Data

Published in partnership with the Health Data Consortium. The Health Data Consortium is a collaboration among government, non-profit, and private sector organizations working to foster the availability and use of health data to drive innovations that improve health and health care.

4 ways groups are harnessing big data to improve cancer treatment

September 4, 2013 11:49 am by | 0 Comments

bigdataThe use of big data to provide more targeted treatments to fight cancer to improve outcomes is steadily evolving. In a bid to combat the second leading of cause of death in the U.S., companies and groups are analyzing the genetics of patients’ cancer cells to indicate which treatments could have the best outcomes and fewest side effects. Some companies are also analyzing data generated by hundreds of thousands of patients to develop treatment recommendations. Here are four companies and groups that are taking different approaches to using big data as part of an effort to improve cancer treatment outcomes.

N-of-One comes in as part of the last step in the big data analysis for oncology. The five year old company uses a decision-making platform for targeted cancer care called PrecisionWorks. It works with diagnostic companies, hospitals and cancer centers. Hospitals send biomarkers electronically to the company database. N-of-One’s team matches patient-specific tumor molecular profiling data with diagnostic technologies and therapeutic options. It identifies relevant clinical strategies for each patient’s unique cancer and sends back a report within 72 hours, according to CEO Christine Cournoyer.

Earlier this year it formed a partnership with Fox Chase Cancer Center in Philadelphia. It provides molecular interpretation and treatment strategy analysis for genome sequencing and testing through the Cancer Genome Institute at Fox Chase. It’s also working with contract research organizations to screen patients for clinical trials based on their molecular profile for MarkerMatch program.

In addition to cancer, it sees opportunities to apply its platform to other molecularly driven diseases such as cardiovascular, neurodegenerative and metabolic diseases.

Advertisement

The American Society of Clinical Oncologists’ CancerLinQ project is using data from 100,000 breast cancer patients from 22 practices in the first prototype of what its developers hope will serve as a nationwide second opinion service for physicians. It is linking together open source and proprietary software to achieve a few different objectives. It wants to be able to accept patient data from electronic health records, lab data, genomic profiles and physician notes. It also wants to provide speedy feedback on physician performance against 10 quality measures. It’s also using open source reference software PopHealth to determine whether patients are getting the right cancer treatment based on their disease profile.

Flatiron Health is in the midst of a pilot to develop the best cancer treatment options using big data. It wants to give physicians access to more meaningful data from a larger patient population. The long-term goal is to give them a better sense of the best treatment options for their cancer patients depending on the type of cancer they have. It also seeks to improve participation in clinical trials. Its platform offers automatic tracking against clinical, operational and financial metrics, monitoring of adherence to national standards, custom guidelines and flexible query and visualization tools to identify trends and patterns in each provider’s cancer patient population. Institutions can see data for their own patients that they are treating but data from other institutions is de-identified.

Eviti launched its Philadelphia-based clinical decision-support program for oncologists in 2009, gaining market entry through payers. It gives oncologists free access to its digital cancer treatment library. More than 1,800 oncologists have accessed the library. It contains data from more than 9,000 federally registered clinical trials and 1,200 evidence-based treatment regimens for 120 cancer types derived from government and industry data.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Stephanie Baum

By Stephanie Baum

Stephanie Baum is the East Coast Innovation Reporter for MedCityNews.com. She enjoys covering healthcare startups across health IT, drug development and medical devices and innovations deployed to improve medical care. She graduated from Franklin & Marshall College in Pennsylvania and has worked across radio, print and video. She's written for The Christian Science Monitor, Dow Jones & Co. and United Business Media.
Visit website | More posts by Author

0 comments

Health Data Consortium

Published in partnership with the Health Data Consortium. The Health Data Consortium is a collaboration among government, non-profit, and private sector organizations working to foster the availability and use of health data to drive innovations that improve health and health care. More information on the Health Data Consortium can be found at HealthDataConsortium.org.


Latest From HDC Blog

#HealthData


Recommended Links

Health Data Consortium

Website | LinkedIn | Twitter

HealthData.gov

Website | Facebook | Twitter

Health Data Initiative Forum

Website


Profiles

Todd Park

United States Chief Technology Officer

Todd Park is the United States Chief Technology Officer and in this role serves as an Assistant to the President. Todd joined the Administration in August 2009 as Chief Technology Officer of the U.S. Department of Health and Human Services (HHS). In this role, he served as a change agent and “entrepreneur-in-residence,” helping HHS harness the power of data, technology, and innovation to improve the health of the nation.


Bryan Sivak

Chief Technology Officer, Department of Health and Human Services

Bryan Sivak joined HHS as the Chief Technology Officer in July 2011. In this role, he is responsible for helping HHS leadership harness the power of data, technology, and innovation to improve the health and welfare of the nation.


Steven Randazzo

Communications Lead for Innovations Team, Department of Health and Human Services

Steven works with the HHS's Chief Technology Officer to promote the formation and adoption of innovative processes and products in government. Steven is the manager of three open data and innovation blogs and his primary duties focus on external communication of the initiatives and priorities undertaken by HHS and outlined in the Open Government Plan.


Jim Cashel

Chairman of Forum One Communications

Forum One Communications is a digital communications firm which works at the nexus of technology, public policy, and online community. With offices in Washington DC, Seattle and San Francisco, Forum One has completed 1000 projects for 300 clients, including foundations, nonprofit organizations, government agencies and commercial groups. Prior to Forum One Jim co-founded the Eurasia Foundation, a Washington, D.C.-based grant-making organization.